Efficacy and Safety of Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars. A Pilot Study.

NCT01213199 Phase 2 COMPLETED Results posted

The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.

Details

Lead sponsor	Galderma R&D
Phase	Phase 2
Status	COMPLETED
Enrolment	20
Start date	2011-03
Completion	2012-09

Conditions

• Acne Scars

Interventions

• Adapalene

Primary outcomes

• Global Scarring Severity — Week 24
  Grade Level: 1. Macular disease 2. Mild disease 3. Moderate disease 4. Severe disease

Countries

United States